• iRhom2 Regulates Olfactory Receptor Expression and Adaptatio

  2026-07-22

  Azzopardi et al. (2024) reveal that iRhom2 is selectively expressed in olfactory sensory neurons, modulating odorant receptor gene expression and adaptation through a negative feedback mechanism. This study provides new insight into the molecular regulation of olfactory function and highlights the interplay between GPCR signaling and iRhom2/ADAM17 activity.

• Tumor Exosomal ENPP1 Inhibits cGAS-STING Signaling via cGAMP

  2026-07-22

  This study uncovers a novel tumor immune evasion mechanism wherein tumor-derived exosomes expressing ENPP1 hydrolyze extracellular 2'3'-cGAMP, thereby suppressing cGAS-STING-mediated innate immune activation. These insights deepen our understanding of tumor–immune crosstalk and highlight the importance of targeting exosomal ENPP1 to improve immunotherapy outcomes.

• Solving Lab Challenges with CHI3L1-IN-5 (Compound Z17, CAS N

  2026-07-21

  This scenario-driven article addresses common laboratory hurdles in cell-based neuroinflammation research and highlights how CHI3L1-IN-5 (Compound Z17, CAS No. 2249043-42-1, SKU C8756) offers reliable, evidence-backed solutions. Researchers gain practical guidance on experimental design, assay optimization, and product selection, grounded in quantitative data and validated workflows.

• Pharmacokinetic Variability of CSBTA Alkaloids in MASH Model

  2026-07-21

  This study systematically characterizes how metabolic dysfunction-associated steatohepatitis (MASH) alters the pharmacokinetics and tissue distribution of Corydalis saxicola Bunting total alkaloids (CSBTA) in mice. The findings reveal that pathological changes in enzyme and transporter expression significantly impact exposure and liver accumulation of key alkaloids, informing dosing strategies for MASLD/MASH research.

• Erastin and Ferroptosis: Translational Leverage for Cancer B

  2026-07-20

  This thought-leadership article synthesizes mechanistic, experimental, and translational insights on Erastin, a gold-standard ferroptosis inducer, focusing on its application in cancer biology and emerging cross-domain opportunities. Leveraging recent spatial transcriptomic studies and advanced product intelligence from APExBIO, the article guides translational researchers on strategic deployment, protocol optimization, and future directions.

• Sodium Risedronate in Glucocorticoid-Induced Osteoporosis wi

  2026-07-20

  The RISOTTO study provides high-quality evidence that sodium risedronate significantly increases lumbar spine bone mineral density (L-BMD) in patients with glucocorticoid-induced osteoporosis (GIO) and rheumatoid arthritis (RA), with a favorable safety profile. This work informs clinical strategies for mitigating bone loss in RA patients receiving glucocorticoid therapy.

• 3-Deazaadenosine: A Benchmark S-Adenosylhomocysteine Hydrola

  2026-07-19

  3-Deazaadenosine is a potent S-adenosylhomocysteine hydrolase inhibitor, unlocking precision control over methylation and antiviral pathways. This guide details rigorous protocols, troubleshooting, and novel applications in epigenetic and viral research, bridging reference breakthroughs with reproducible lab workflows.

• Phosphoenolpyruvate Restricts Inflammaging via cGAS-STING In

  2026-07-18

  A recent study reveals that phosphoenolpyruvate (PEP), a glycolytic metabolite, acts as an endogenous inhibitor of the cGAS-STING pathway, thus limiting chronic inflammation and promoting healthy aging. This mechanistic insight positions metabolic intermediates as critical regulators of inflammaging, with implications for translational research on aging and neurodegeneration.

• X-Gal in Translational Research: Mechanistic Leverage and St

  2026-07-17

  This article explores the mechanistic underpinnings and translational potential of X-Gal (5-bromo-4-chloro-indolyl-β-D-galactopyranoside) as a chromogenic substrate in molecular biology. By integrating recent findings on olfactory receptor adaptation and established protocol best practices, we provide strategic guidance for researchers seeking to harness X-Gal beyond classic blue-white screening, with evidence-backed recommendations for maximizing data fidelity and workflow efficiency.

• Indometacin Sodium: Mechanistic Leverage for Translational P

  2026-07-17

  This thought-leadership article explores how Indometacin Sodium Trihydrate, a high-purity NSAID, goes beyond COX inhibition to enable advanced translational research in inflammation, pain, and neuroregeneration. We dissect mechanistic insights, experimental design imperatives, and clinical relevance, bridging evidence from cell-based assays to the clinical context of rheumatoid arthritis and glucocorticoid-induced osteoporosis. Protocol parameters are detailed, with strategic guidance on workflow optimization and translational fit, and a clear-eyed outlook on opportunities and limitations.

• Immune Signatures Induced by Epigenetic Targeting in Melanom

  2026-07-16

  Anichini et al. provide a systematic comparison of immune-related transcriptional changes in melanoma cell lines induced by distinct epigenetic inhibitors. Their work highlights guadecitabine, a DNMT inhibitor, as uniquely capable of upregulating immune pathways linked to improved immunotherapy outcomes, suggesting new avenues for combinatorial cancer treatment.

• Cheminformatics-Driven Optimization of Small-Molecule Librar

  2026-07-16

  Moret et al. (2019) present a data-driven approach to analyzing and designing small-molecule libraries, optimizing for target selectivity and coverage. Their methodology enables researchers to assemble compound collections with minimized off-target overlap, enhancing the effectiveness of chemical biology and drug discovery studies.

• HMGCS2 Loss Drives Lyso-PC–Mediated Fibroblast Activation in

  2026-07-15

  Yang et al. (2024) elucidate how loss of HMGCS2 in alveolar epithelial cells disrupts lipid metabolism, leading to accumulation of 14:0 Lyso-PC, which directly activates fibroblasts and promotes pulmonary fibrosis. Their work clarifies the cellular origin and mechanistic impact of lysophospholipid signaling in fibrotic progression, providing a foundation for new experimental and therapeutic strategies.

• Berberine Hydrochloride: Next-Gen Modulator of Ferroptosis a

  2026-07-15

  Explore how Berberine Hydrochloride uniquely bridges metabolic regulation and inflammation control via ferroptosis and pyroptosis modulation. This in-depth article reveals cutting-edge mechanisms and assay insights, distinct from existing metabolic or inflammasome-focused guides.

• Eicosapentaenoic Acid (EPA): Integrating Membrane Modulation

  2026-07-14

  Explore how Eicosapentaenoic Acid (EPA) advances cardiovascular disease research as an EPA omega-3 fatty acid, uniquely focusing on membrane modulation, lipid oxidation, and the nuanced cross-talk with humoral immunity. Discover workflow-critical insights that set this article apart from prior discussions.

15171 records 1/1012 page Next 12345 下5页 Last page